• Corpus ID: 11751953

Epidemiology, Prevention and Control of Hepatitis B virus Infection in China

  title={Epidemiology, Prevention and Control of Hepatitis B virus Infection in China},
  author={Bo Qin and Guozhong Zhou and Xuejun Dong},
  journal={Research and Reviews: Journal of Microbiology and Biotechnology},
Hepatocellular carcinoma (HCC) is one of the major keys to cause cancer-related mortality in the whole world, with the majority of patients related to persistent infection of hepatitis B virus (HBV), especially in Asian and African, while HCV in Europe and America. HBV is the smallest DNA-containing, enveloped mammal virus known so far. High tissue and species specii¬city, unique genome and replication mechanism make HBV be shrouded in mystery. A high HBV load is the most significant risk… 



The impact of anti-HBV treatment on the occurrence and recurrence of hepatocellular carcinoma: focus on Asian studies.

This review will focus on Asian clinical studies, where there is a higher prevalence of CHB and HCC, and the outcomes of antiviral therapies on HCC in these Asian studies were compared to those in the Western studies.

Epidemiology and Prevention of Hepatitis B Virus Infection

The implement of mass HBV immunization program is recommended by the WHO since 1991, and has dramatically decreased the prevalence of HBV infection and HCC in many countries.

Epidemiology and prevention of hepatitis B virus infection in China

More efforts are needed to improve and develop strategies for the control of HBV infection in China, particularly after implementing the policy of universal HBV immunization for all newborns.

Introduction to Chronic Hepatitis B Infection

  • T. Wright
  • Medicine, Biology
    The American Journal of Gastroenterology
  • 2006
While novel anti-viral drugs have improved the management of cirrhosis, strategies to prevent and treat HCC remain inadequate.

New insight in the pathobiology of hepatitis B virus infection

Current knowledge of factors influencing the course of HBV infection is summarized, giving emphasis on the use of novel assays and quantitative serological and intrahepatic biomarkers as tools for predicting treatment response and disease progression.

Therapeutic vaccination against chronic hepatitis B virus infection.

  • M. MichelM. Mancini-Bourgine
  • Biology, Medicine
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
  • 2005

Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)

Viral treatment for HBV-associated HCC is described as a strategy to reduce recurrence and improve survival in the present review.

Molecular epidemiology of HBV infection in chronic hepatitis B virus infected patients in northeast India

Higher presence of e‐positive cases and genotype C along with the mixed genotypes in NEI is unique and of significance with reference to predisposition to disease severity and even response to antiviral therapy.

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

It is shown that cellular inhibitor of apoptosis proteins (cIAPs) attenuate TNF signaling during hepatitis B infection, and they restrict the death of infected hepatocytes, thus allowing viral persistence.